Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BridgeBio Pharma (BBIO) Return on Equity (2019 - 2025)

BridgeBio Pharma (BBIO) has disclosed Return on Equity for 7 consecutive years, with 0.35% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 4.0% to 0.35% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.35% through Dec 2025, down 4.0% year-over-year, with the annual reading at 0.41% for FY2025, 3.0% up from the prior year.
  • Return on Equity hit 0.35% in Q4 2025 for BridgeBio Pharma, down from 0.42% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 4.09% in Q1 2021 to a low of 0.35% in Q4 2025.
  • Historically, Return on Equity has averaged 0.74% across 5 years, with a median of 0.48% in 2023.
  • Biggest five-year swings in Return on Equity: soared 476bps in 2021 and later tumbled -342bps in 2022.
  • Year by year, Return on Equity stood at 0.78% in 2021, then crashed by -36bps to 0.49% in 2022, then grew by 7bps to 0.53% in 2023, then fell by -26bps to 0.39% in 2024, then dropped by -11bps to 0.35% in 2025.
  • Business Quant data shows Return on Equity for BBIO at 0.35% in Q4 2025, 0.42% in Q3 2025, and 0.44% in Q2 2025.